These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8095146)

  • 21. CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study.
    Phillips AN; Pezzotti P; Lepri AC; Rezza G
    AIDS; 1994 Sep; 8(9):1299-305. PubMed ID: 7802984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low AIDS attack rate among Dutch haemophiliacs compared to homosexual men: a correlate of HIV antigenaemia frequencies.
    Wolfs TF; de Wolf F; Breederveld C; Sjamsjoedin-Visser LJ; Roos M; Bakker M; Goudsmit J
    Vox Sang; 1989; 57(2):127-32. PubMed ID: 2571211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actuarial rate of clinical and biological progression in a cohort of 250 HIV-1-seropositive subjects. Laennec HIV Study Group.
    Venet A; Tourani JM; Beldjord K; Eme D; Even P; Andrieu JM
    Clin Exp Immunol; 1990 May; 80(2):151-5. PubMed ID: 1972669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time.
    Farzadegan H; Chmiel JS; Odaka N; Ward L; Poggensee L; Saah A; Phair JP
    J Infect Dis; 1992 Dec; 166(6):1217-22. PubMed ID: 1358985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p24 antigenaemia, CD4 lymphocyte counts and the development of AIDS.
    Phillips AN; Lee CA; Elford J; Webster A; Janossy G; Griffiths PD; Kernoff PB
    AIDS; 1991 Oct; 5(10):1217-22. PubMed ID: 1686179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.
    Katzenstein TL; Pedersen C; Nielsen C; Lundgren JD; Jakobsen PH; Gerstoft J
    AIDS; 1996 Feb; 10(2):167-73. PubMed ID: 8838704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection.
    Lifson AR; Hessol NA; Buchbinder SP; O'Malley PM; Barnhart L; Segal M; Katz MH; Holmberg SD
    Lancet; 1992 Jun; 339(8807):1436-40. PubMed ID: 1351128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
    Rezza G; Galai N; Pezzotti P; Vlahov D; Graham NM; Viale P; Angarano G
    Antivir Ther; 1997 Jul; 2(3):167-74. PubMed ID: 11322271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study.
    Saah AJ; Muñoz A; Kuo V; Fox R; Kaslow RA; Phair JP; Rinaldo CR; Detels R; Polk BF
    Am J Epidemiol; 1992 May; 135(10):1147-55. PubMed ID: 1352940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.
    Moss AR; Bacchetti P; Osmond D; Krampf W; Chaisson RE; Stites D; Wilber J; Allain JP; Carlson J
    Br Med J (Clin Res Ed); 1988 Mar; 296(6624):745-50. PubMed ID: 3126959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group.
    AIDS; 1997 Oct; 11(12):1509-17. PubMed ID: 9342074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?
    Lindbäck S; Broström C; Karlsson A; Gaines H
    BMJ; 1994 Dec; 309(6968):1535-7. PubMed ID: 7819891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The prognostic markers of HIV infection progression. A study of the p24 antigen in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T
    An Med Interna; 1999 Sep; 16(9):447-50. PubMed ID: 10609356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
    Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
    AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.
    Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
    BMJ; 1994 Jul; 309(6950):309-13. PubMed ID: 7916226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion.
    Geskus RB
    Stat Med; 2000 Jul; 19(13):1753-69. PubMed ID: 10861776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
    AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual men.
    Veugelers PJ; Schechter MT; Tindall B; Moss AR; Page KA; Craib KJ; Cooper DA; Coutinho RA; Charlebois E; Winkelstein W
    AIDS; 1993 Oct; 7(10):1325-9. PubMed ID: 7903540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
    Hazenberg MD; Otto SA; van Benthem BH; Roos MT; Coutinho RA; Lange JM; Hamann D; Prins M; Miedema F
    AIDS; 2003 Sep; 17(13):1881-8. PubMed ID: 12960820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.